Vistagen Therapeutics (VTGN) EPS (Basic) Growth (5y) (2017 - 2026)
Vistagen Therapeutics (VTGN) EPS (Basic) Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Vistagen Therapeutics | 10.41 Mn | 10.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.06% |
| Dec 31, 2025 | 26.54% |
| Sep 30, 2025 | 19.73% |
| Jun 30, 2025 | 25.24% |
| Mar 31, 2025 | 29.07% |
| Dec 31, 2024 | 36.28% |
| Sep 30, 2024 | 36.12% |
| Jun 30, 2024 | 40.19% |
| Mar 31, 2024 | 39.98% |
| Dec 31, 2023 | 50.59% |
| Sep 30, 2023 | 40.73% |
| Jun 30, 2023 | 30.71% |
| Mar 31, 2023 | 28.46% |
| Dec 31, 2022 | 28.33% |
| Sep 30, 2022 | 30.76% |
| Jun 30, 2022 | 19.21% |
| Mar 31, 2022 | 25.61% |
| Dec 31, 2021 | 31.15% |
| Sep 30, 2021 | 30.34% |
| Jun 30, 2021 | 39.20% |